Nupercainal en es it fr

Nupercainal Brand names, Nupercainal Analogs

Nupercainal Brand Names Mixture

  • No information avaliable

Nupercainal Chemical_Formula

C21H27NO

Nupercainal RX_link

No information avaliable

Nupercainal fda sheet

Nupercainal FDA

Nupercainal msds (material safety sheet)

Nupercainal MSDS

Nupercainal Synthesis Reference

No information avaliable

Nupercainal Molecular Weight

309.445 g/mol

Nupercainal Melting Point

No information avaliable

Nupercainal H2O Solubility

No information avaliable

Nupercainal State

Solid

Nupercainal LogP

4.86

Nupercainal Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Nupercainal Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Nupercainal Pharmacology

No information avaliable

Nupercainal Absorption

Well absorbed from gastrointestinal tract following oral administration.

Nupercainal side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Nupercainal Patient Information

No information avaliable

Nupercainal Organisms Affected

Humans and other mammals